Advanced search
Publication Cover
Pharmaceutical Biology Volume 57, 2019 - Issue 1
Submit an article Journal homepage
1,924
Views
9
CrossRef citations to date
0
Altmetric
Research Article

The clickable activity-based probe of anti-apoptotic calenduloside E

Yu TianBeijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Key Laboratory of Bioactive Substances and Resources, Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Key Laboratory of Efficacy Evaluation of Chinese Medicine against Glycolipid Metabolic Disorders, State Administration of Traditional Chinese Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Zhong guan cun Open Laboratory of the Research and Development of Natural Medicine and Health Products, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Key Laboratory of new drug discovery based on Classic Chinese Academy of Medical Sciences; ORCID Iconhttp://orcid.org/0000-0002-5997-1456View further author information
ORCID Icon,
Shan WangBeijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Key Laboratory of Bioactive Substances and Resources, Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Key Laboratory of Efficacy Evaluation of Chinese Medicine against Glycolipid Metabolic Disorders, State Administration of Traditional Chinese Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Zhong guan cun Open Laboratory of the Research and Development of Natural Medicine and Health Products, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Key Laboratory of new drug discovery based on Classic Chinese Academy of Medical Sciences; View further author information
,
Hai ShangBeijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Key Laboratory of Bioactive Substances and Resources, Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Key Laboratory of Efficacy Evaluation of Chinese Medicine against Glycolipid Metabolic Disorders, State Administration of Traditional Chinese Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Zhong guan cun Open Laboratory of the Research and Development of Natural Medicine and Health Products, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Key Laboratory of new drug discovery based on Classic Chinese Academy of Medical Sciences; View further author information
,
Wen-Qian WangTianjin Institute of Pharmaceutical Research, Tianjin, China; View further author information
,
Bao-Qi WangCenter of Research and Development on Life Sciences and Environment Sciences, Harbin University of Commerce, Harbin, ChinaView further author information
,
Xi ZhangCenter of Research and Development on Life Sciences and Environment Sciences, Harbin University of Commerce, Harbin, ChinaView further author information
,
Xu-Dong XuBeijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Key Laboratory of Bioactive Substances and Resources, Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Key Laboratory of Efficacy Evaluation of Chinese Medicine against Glycolipid Metabolic Disorders, State Administration of Traditional Chinese Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Zhong guan cun Open Laboratory of the Research and Development of Natural Medicine and Health Products, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Key Laboratory of new drug discovery based on Classic Chinese Academy of Medical Sciences; Correspondence[email protected]
View further author information
,
Gui-Bo SunBeijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Key Laboratory of Bioactive Substances and Resources, Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Key Laboratory of Efficacy Evaluation of Chinese Medicine against Glycolipid Metabolic Disorders, State Administration of Traditional Chinese Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Zhong guan cun Open Laboratory of the Research and Development of Natural Medicine and Health Products, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Key Laboratory of new drug discovery based on Classic Chinese Academy of Medical Sciences; Correspondence[email protected]
View further author information
&
Xiao-Bo SunBeijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Key Laboratory of Bioactive Substances and Resources, Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Key Laboratory of Efficacy Evaluation of Chinese Medicine against Glycolipid Metabolic Disorders, State Administration of Traditional Chinese Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Zhong guan cun Open Laboratory of the Research and Development of Natural Medicine and Health Products, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ;Key Laboratory of new drug discovery based on Classic Chinese Academy of Medical Sciences; Correspondence[email protected]
View further author information
 show all
Pages 133-139 | Received 31 Aug 2018, Accepted 04 Dec 2018, Published online: 07 Mar 2019

References

  • Cannon MJ, Papalia GA, Navratilova I, Fisher RJ, Roberts LR, Worthy KM, Stephen AG, Marchesini GR, Collins EJ, Casper DH, et al. 2004. Comparative analyses of a small molecule/enzyme interaction by multiple users of Biacore technology. Anal. Biochem. 330:98–113.
  • Cui GZ, Shan L, Chu IK, Li GH, Leung GPH, Wang YQ, Kwan YW, Chan SW, Hoi MPM, Lee SMY. 2015. Identification of disulfide isomerase ERp57 as a target for small molecule cardioprotective agents. RSC Adv. 5:74605–74610.
  • Eder J, Sedrani R, Wiesmann C. 2014. The discovery of first-in-class drugs: origins and evolution. Nat Rev Drug Discov. 13:577–587.
  • Guiffant D, Tribouillard D, Gug F, Galons H, Meijer L, Blondel M, Bach S. 2007. Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography. Biotechnol J. 2:68–75.
  • Li N, Overkleeft HS, Florea BI. 2012. Activity-based protein profiling: an enabling technology in chemical biology research. Curr Opin Chem Biol. 16:227–233.
  • Lomenick B, Olsen RW, Huang J. 2011. Identification of direct protein targets of small molecules. ACS Chem Biol. 6:34–46.
  • Martell J, Weerapana E. 2014. Applications of copper-catalyzed click chemistry in activity-based protein profiling. Molecules. 19:1378–1393.
  • Nhiem NX, Lim HY, Kiem PV, Minh CV, Thu VK, Tai BH, Quang TH, Song SB, Kim YH. 2011. Oleanane-type triterpene saponins from the bark of Aralia elata and their NF-κB inhibition and PPAR activation signal pathway. Bioorganic Med Chem Lett. 21:6143–6147.
  • Nguyen HH, Park J, Kang S, Kim M. 2015. Surface plasmon resonance: a versatile technique for biosensor applications. Sensors (Basel, Switzerland). 15:10481–10510.
  • Overington JP, AL-Lazikani B, Hopkins AL. 2006. How many drug targets are there? Nat Rev Drug Discov. 5:993–996.
  • Qin M, Luo Y, Meng XB, Wang M, Wang HW, Song SY, Ye JX, Pan RL, Yao F, Wu P, et al. 2015. Myricitrin attenuates endothelial cell apoptosis to prevent atherosclerosis: an insight into PI3K/Akt activation and STAT3 signaling pathways. Vasc Pharmacol. 70:23–34.
  • Rollinger JM, Schuster D, Danzl B, Schwaiger S, Markt P, Schmidtke M, Gertsch J, Raduner S, Wolber G, Langer T, et al. 2009. In silico target fishing for rationalized ligand discovery exemplified on constituents of Ruta graveolens. Planta Medica. 75:195–204.
  • Schmidt RR, Michel J. 1980. Facile synthesis of α- and β-O-glycosyl imidates: preparation of glycosides and disaccharides. Angewandte Chemie Int Ed. 19:731–732.
  • Speers AE, Cravatt BF. 2009. Activity-based protein profiling (ABPP) and click chemistry (CC)-ABPP by MudPIT mass spectrometry. Curr Protoc Chem Biol. 1:29–41.
  • Tian Y, Wang S, Shang H, Wang M, Sun GB, Xu XD, Sun XB. 2017. The proteomic profiling of calenduloside E targets in HUVEC: design, synthesis and application of biotinylated probe BCEA. RSC Adv. 7:6259–6265.
  • Tian Y, Du YY, Shang H, Wang M, Sun ZH, Wang BQ, Deng D, Shan W, Xu XD, Sun GB, et al. 2017. Calenduloside E analogues protecting H9c2 cardiomyocytes against H2O2-induced apoptosis: design, synthesis and biological evaluation. Front Pharmacol. 8:862.
  • Tian Y, Sun ZH, Wang WQ, Shang H, Wang BQ, Deng D, Ma GX, Wu HF, Liang ZN, Xu XD, et al. 2018. Semisynthesis and biological evaluation of oleanolic acid 3-O-β-d-glucuronopyranoside derivatives for protecting H9c2 cardiomyoblasts against H2O2-induced injury. Molecules. 23:44.
  • Wang M, Xu XD, Xu HB, Wen FC, Zhang XP, Sun H, Yao F, Sun GB, Sun XB. 2014. Effect of the total saponins of Aralia elata (Miq) Seem on cardiac contractile function and intracellular calcium cycling regulation. J Ethnopharmacol. 155:240–247.
  • Wang JG, Zhang CJ, Zhang JB, He YK, Lee YM, Chen SB, Lim TK, Ng SK, Shen HM, Lin QS. 2015. Mapping sites of aspirin-induced acetylations in live cells by quantitative acid-cleavable activity-based protein profiling (QA-ABPP). Sci Rep. 5:7896–7907.
  • Wang JG, Zhang JB, Zhang CJ, Wong YK, Lim TK, Hua ZC, Liu B, Tannenbaum SR, Shen HM, Lin QS. 2016. In situ proteomic profiling of curcumin targets in HCT116 colon cancer cell line. Sci Rep. 6:22146–22153.
  • Wang S, Tian Y, Zhang JY, Xu HB, Zhou P, Wang M, Lu SB, Luo Y, Wang M, Sun GB, et al. 2018. Targets fishing and identification of calenduloside E as Hsp90AB1: design, synthesis, and evaluation of clickable activity-based probe. Front Pharmacol. 9:532.
  • Yi X, Zhong B, Smith KM, Geldenhuys WJ, Feng Y, Pink JJ, Dowlati A, Xu Y, Zhou A, Su B. 2012. Identification of a class of novel tubulin inhibitors. J Med Chem. 55:3425–3435.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.